Biontech inks deal with UK on sped-up cancer trials
From the fall of this year, cancer patients in the UK will have access to new mRNA-based cancer therapies from Biontech as part of clinical testing.
by christian bundgaard, translated by daniel pedersen
An agreement between the UK government and German Biontech could give cancer patients residing in the country access to mRNA-based cancer therapies being tested in clinical trials, reports The Guardian.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
